| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TNDM | Common Stock | +Grant/Award | $12,715 | +813 | +12.66% | $15.64 | 7,236 | May 15, 2024 | Direct | F1 |
| transaction | TNDM | Common Stock | +Options Exercise | $0 | +162 | +2.24% | $0.00 | 7,398 | May 15, 2024 | Direct | |
| transaction | TNDM | Common Stock | -Tax liability | -$2,747 | -58 | -0.78% | $47.37 | 7,340 | May 15, 2024 | Direct | F2 |
| transaction | TNDM | Common Stock | +Options Exercise | $0 | +474 | +6.46% | $0.00 | 7,814 | May 15, 2024 | Direct | |
| transaction | TNDM | Common Stock | -Tax liability | -$8,053 | -170 | -2.18% | $47.37 | 7,644 | May 15, 2024 | Direct | F2 |
| transaction | TNDM | Common Stock | +Options Exercise | $0 | +6,012 | +78.65% | $0.00 | 13,656 | May 15, 2024 | Direct | |
| transaction | TNDM | Common Stock | -Tax liability | -$101,656 | -2,146 | -15.71% | $47.37 | 11,510 | May 15, 2024 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TNDM | Restricted Stock Unit | -Options Exercise | $0 | -162 | -19.95% | $0.00 | 650 | May 15, 2024 | Common Stock | 162 | Direct | F3, F4, F5 | |
| transaction | TNDM | Restricted Stock Unit | -Options Exercise | $0 | -474 | -19.99% | $0.00 | 1,897 | May 15, 2024 | Common Stock | 474 | Direct | F4, F6, F7 | |
| transaction | TNDM | Restricted Stock Unit | -Options Exercise | $0 | -6,012 | -33.33% | $0.00 | 12,025 | May 15, 2024 | Common Stock | 6,012 | Direct | F8, F9, F10 |
| Id | Content |
|---|---|
| F1 | The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2023 through May 15, 2024. This transaction is also exempt under Rule 16b-3(c). |
| F2 | Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. |
| F3 | Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). |
| F4 | Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. |
| F5 | RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. |
| F6 | Awarded on May 25, 2022 pursuant to the 2013 Plan. |
| F7 | RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. |
| F8 | Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). |
| F9 | Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. |
| F10 | RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. |